Concern
Wrinkles & Fine Lines

A New Rapid-Onset Neurotoxin Was Just Approved. Could It Disrupt Injectables?
Boey is the first rapid-onset, short-duration neurotoxin, with results that can begin in hours and fade within weeks. Approved in Canada and Europe this summer, it offers a fast-acting, shorter-lasting alternative to traditional toxins like Botox. Three Vos Collection physicians explain who it could suit.

Your Fall Treatment Plan: Why and How to Repair Your Skin This Season
You’re back from summer with a few new sunspots or rougher texture, and wondering what’s worth booking before the holidays. Experts across the Vos Collection network weigh in on what to prioritize this fall, and when to start.

Five Trends We Saw in Clinic, Summer ’26
TikTok can make a treatment look like the next big thing overnight, but the appointments filling clinic schedules tell a different story. Vos Collection physicians on the five trends that defined summer 2026, from skin tightening to a new take on filler.

The FDA Reviewed 7 Popular Peptides. Six Made the Cut.
Khloé Kardashian, Hailey Bieber, Joe Rogan, and the longevity crowd are all on peptides. In late July an FDA panel reviewed seven and recommended six for compounding. What each one really is — and how much evidence is behind them.
Expect Remarkable
Care that closes the distance between how you look and how you feel.